The past month, the nation's eyes have been trained on Washington and an already volatile political environment that seems to be getting more chaotic by the day. STAT has been on it.
We published a must-read primer on former President Trump's running mate, JD Vance, Vance's positions on health care issues, and his venture capital investments in the industry. We combed through Vice President Kamala Harris' record to bring you a comprehensive accounting of her stances on health care. And down ballot, we dug into how the departure of senior lawmakers amounts to a tough break for the pharmaceutical industry.
This is the kind of journalism we think is worth paying for.
Our team will continue to report on what precisely the candidates are promising to do. We've previously covered the policy positions the Republican Party has already released, including its shifting stances on abortion. And when politicians aren't entirely truthful, we will hold them accountable. You may have seen I fact-checked former claims by Trump and President Biden that they lowered insulin costs.
My D.C. colleagues, including Sarah Owermohle and John Wilkerson, bring decades of experience to our coverage. That means our team is wired with sources on K Street, Capitol Hill, the White House, executive agencies, and advocacy communities. Recently we broke the news of a massive restructuring at the biotechnology industry lobbying group BIO, and we were the first to report on a bill that could result in the first Medicare coverage of obesity medications. Back in the spring, we confirmed with 11 sources that reform to how pharmacy middlemen work was being left out of a major legislative effort.
Health policy is complicated, and you can depend on us to go beyond the press releases to explain the latest developments.
We aspire to be tough and fair in a highly charged environment. Sometimes, we write articles that powerful people don't like.
To do this work, we are reliant on subscribers. If you are not currently among them, I'd like to urge you to consider subscribing. I think you'll find the coverage both urgent and important. For a limited time, you can get 30% off your first year of STAT+ with code JULY30.
Thank you for your time and consideration.
No comments